Molecular Mechanisms in Progressive Idiopathic Pulmonary Fibrosis

被引:90
|
作者
Steele, Mark P. [1 ]
Schwartz, David A. [2 ,3 ]
机构
[1] Vanderbilt Univ, Sch Med, Lung Transplant Program, Div Allergy Pulm & Crit Care Med, Nashville, TN 37332 USA
[2] Univ Colorado, Sch Med, Aurora, CO 80045 USA
[3] Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO 80206 USA
来源
ANNUAL REVIEW OF MEDICINE, VOL 64 | 2013年 / 64卷
关键词
familial pulmonary fibrosis; familial interstitial pneumonia; telomerase; surfactant proteins; mucin; 5B; SURFACTANT-PROTEIN-C; NONSPECIFIC INTERSTITIAL PNEUMONIA; ENDOPLASMIC-RETICULUM STRESS; ALVEOLAR EPITHELIAL-CELLS; DYSKERATOSIS-CONGENITA; GENE; MUTATIONS; DISEASE; RISK; SUSCEPTIBILITY;
D O I
10.1146/annurev-med-042711-142004
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
There is clear evidence that environmental exposures and genetic predisposition contribute to the pathogenesis of idiopathic pulmonary fibrosis (IPF). Cigarette smoking increases the risk of developing IPF several-fold, as do other exposures such as metal-fume and wood-dust exposure. Occupations that increase the risk of IPF are agricultural work, hairdressing, and stone polishing, supporting the role of environmental exposure in disease pathogenesis. Genetic predisposition to IPF is evident from its familial aggregation and the fact that pulmonary fibrosis develops in several rare genetic disorders. Mutations in surfactant proteins lead to pulmonary fibrosis and are associated with endoplasmic reticulum stress in alveolar type II epithelial cells. Mutations in telomerase have been found in several families with IPF, and shortened telomeres are found in sporadic cases of IPF. A common variant in mucin 5B predisposes to both familial and sporadic IPF and is present in the majority of cases, indicating sporadic IPF occurs in those with genetic predisposition.
引用
收藏
页码:265 / 276
页数:12
相关论文
共 50 条
  • [21] Investigating the molecular crosstalk mechanisms that drive pathogenesis in idiopathic pulmonary fibrosis
    Kyriakou, Theano
    Yu, Lu-Gang
    Morgan, Mark
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2023, 104 (02) : A10 - A10
  • [22] Antifibrotic treatment response comparison of progressive pulmonary fibrosis and idiopathic pulmonary fibrosis
    Ozyurek, Berna Akinci
    Ensarioglu, Kerem
    Ozdemirel, Tugce Sahin
    Akkurt, Esma Sevil
    Ozdag, Ozlem
    Zenbilli, Esma
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2024, 54 (05)
  • [23] Summary for Clinicians: Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults
    Herman, Derrick D.
    Ghazipura, Marya
    Raghu, Ganesh
    Richeldi, Luca
    Remy-Jardin, Martine
    Ruminjo, Joseph K.
    Thomson, Carey C.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2023, 20 (05) : 632 - 637
  • [24] Molecular biomarkers in idiopathic pulmonary fibrosis
    Ley, Brett
    Brown, Kevin K.
    Collard, Harold R.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2014, 307 (09) : L681 - L691
  • [25] Molecular Signatures of Idiopathic Pulmonary Fibrosis
    Konigsberg, Iain R.
    Borie, Raphael
    Walts, Avram D.
    Cardwell, Jonathan
    Rojas, Mauricio
    Metzger, Fabian
    Hauck, Stefanie M.
    Fingerlin, Tasha E.
    Yang, Ivana, V
    Schwartz, David A.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2021, 65 (04) : 430 - 441
  • [26] Molecular genetics of idiopathic pulmonary fibrosis
    Mustafin, R. N.
    VAVILOVSKII ZHURNAL GENETIKI I SELEKTSII, 2022, 26 (03): : 308 - 318
  • [27] Abnormal Lymphangiogenesis in Idiopathic Pulmonary Fibrosis: Insights into Cellular and Molecular Mechanisms.
    El-Chemaly, S.
    Malide, D.
    Zudaire, E.
    Ikeda, Y.
    Weinberg, B.
    Pacheco-Rodriguez, G.
    Rosas, I. O.
    MacDonald, S. D.
    Wu, H. P.
    Cuttitta, F.
    McCoy, J. P.
    Gochuico, B. R.
    Moss, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [28] Molecular mechanisms of pulmonary fibrosis
    Pardo, A
    Selman, M
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2002, 7 : D1743 - D1761
  • [29] PROGRESSIVE MASSIVE FIBROSIS ASSOCIATED WITH IDIOPATHIC PULMONARY HEMOSIDEROSIS
    BUSCHMAN, DL
    BALLARD, R
    CHEST, 1993, 104 (01) : 293 - 295
  • [30] Pirfenidone therapy for patients with progressive idiopathic pulmonary fibrosis
    Ihle, Franziska
    Veith, Tobias
    Gregor, Zimmermann
    Gabriela, Wypior
    Juergen, Behr
    Claus, Neurohr
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44